FDA Expands Gene Therapy for Younger Patients

• by Kathryn Wighton

• July 2, 2026

Spinal ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes with a focus on the pediatric population (Part III of ependymomas across compartments)

• by Anthony M. Price, Nathan S. Fredricks, George Koutsouras, Frederic A. Vallejo, Christopher Bonfield, Devang J. Pastakia, Leo Y. Luo, Frederick Boop, Vijay Ramaswamy, Michael C. Dewan

• October 6, 2026

Effectiveness and safety of the available preventive tuberculosis treatment regimens for children and adolescents: systematic review and network meta-analysis

• by Vanessa Sabella-Jiménez, Dione Benjumea-Bedoya, Yenifer Hoyos-Mendez, Andrés Felipe Estupiñán-Bohorquez, Jorge Acosta-Reyes, Ivan D Florez

• September 30, 2026

Nirsevimab may curb RSV severity

Real-world estimates showed protection across emergency, inpatient, and intensive care settings during Canada’s first universal immunization season.

• by Andrea Surnit

• September 18, 2026

• 3 min